Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
18
pubmed:dateCreated
2011-6-20
pubmed:abstractText
This multicenter, randomized, double-blind, phase II study assessed safety and efficacy of axitinib plus docetaxel in metastatic breast cancer (MBC).
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1527-7755
pubmed:author
pubmed:issnType
Electronic
pubmed:day
20
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2459-65
pubmed:meshHeading
pubmed-meshheading:21555686-Adult, pubmed-meshheading:21555686-Aged, pubmed-meshheading:21555686-Angiogenesis Inhibitors, pubmed-meshheading:21555686-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:21555686-Breast Neoplasms, pubmed-meshheading:21555686-Carcinoma, Ductal, Breast, pubmed-meshheading:21555686-Chemotherapy, Adjuvant, pubmed-meshheading:21555686-Combined Modality Therapy, pubmed-meshheading:21555686-Disease-Free Survival, pubmed-meshheading:21555686-Double-Blind Method, pubmed-meshheading:21555686-Female, pubmed-meshheading:21555686-Gastrointestinal Diseases, pubmed-meshheading:21555686-Humans, pubmed-meshheading:21555686-Hypertension, pubmed-meshheading:21555686-Imidazoles, pubmed-meshheading:21555686-Indazoles, pubmed-meshheading:21555686-Middle Aged, pubmed-meshheading:21555686-Mucositis, pubmed-meshheading:21555686-Neoplasm Proteins, pubmed-meshheading:21555686-Neutropenia, pubmed-meshheading:21555686-Protein Kinase Inhibitors, pubmed-meshheading:21555686-Receptors, Vascular Endothelial Growth Factor, pubmed-meshheading:21555686-Taxoids, pubmed-meshheading:21555686-Thrombophilia
pubmed:year
2011
pubmed:articleTitle
Randomized, placebo-controlled, double-blind, phase II study of axitinib plus docetaxel versus docetaxel plus placebo in patients with metastatic breast cancer.
pubmed:affiliation
University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero Ave, Second Floor, Box 1710, San Francisco, CA 94115, USA. hrugo@medicine.ucsf.edu
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase II